About the Authors
- Audrey Rouault
-
Affiliation French National Institute of Health and Medical Research (INSERM) Unit 916, University of Bordeaux, Bergonié Cancer Institute, Bordeaux, France
- Guillaume Banneau
-
Affiliation French National Institute of Health and Medical Research (INSERM) Unit 916, University of Bordeaux, Bergonié Cancer Institute, Bordeaux, France
- Gaëtan MacGrogan
-
Affiliations French National Institute of Health and Medical Research (INSERM) Unit 916, University of Bordeaux, Bergonié Cancer Institute, Bordeaux, France, Pathology Department, Bergonié Cancer Institute, Bordeaux, France
- Natalie Jones
-
Affiliation French National Institute of Health and Medical Research (INSERM) Unit 916, University of Bordeaux, Bergonié Cancer Institute, Bordeaux, France
- Nabila Elarouci
-
Affiliation Cartes d’Identité des Tumeurs (CIT) Program, Ligue Nationale Contre Le Cancer, Paris, France
- Emmanuelle Barouk-Simonet
-
Affiliation Cancer Genetics Unit, Bergonié Cancer Institute, Bordeaux, France
- Laurence Venat
-
Affiliation Department of Medical Oncology, Dupuytren University Hospital, Limoges, France
- Isabelle Coupier
-
Affiliation Cancer Genetics Unit, Val d’Aurelle Regional Cancer Centre, Montpellier, France
- Eric Letouzé
-
Affiliation Cartes d’Identité des Tumeurs (CIT) Program, Ligue Nationale Contre Le Cancer, Paris, France
- Aurélien de Reyniès
-
Affiliation Cartes d’Identité des Tumeurs (CIT) Program, Ligue Nationale Contre Le Cancer, Paris, France
- Françoise Bonnet
-
Affiliations French National Institute of Health and Medical Research (INSERM) Unit 916, University of Bordeaux, Bergonié Cancer Institute, Bordeaux, France, Cancer Genetics Unit, Bergonié Cancer Institute, Bordeaux, France
- Richard Iggo
-
* E-mail: r.iggo@bordeaux.unicancer.fr
Affiliation French National Institute of Health and Medical Research (INSERM) Unit 916, University of Bordeaux, Bergonié Cancer Institute, Bordeaux, France
- Nicolas Sévenet
-
Affiliations French National Institute of Health and Medical Research (INSERM) Unit 916, University of Bordeaux, Bergonié Cancer Institute, Bordeaux, France, Cancer Genetics Unit, Bergonié Cancer Institute, Bordeaux, France
- Michel Longy
-
Affiliations French National Institute of Health and Medical Research (INSERM) Unit 916, University of Bordeaux, Bergonié Cancer Institute, Bordeaux, France, Cancer Genetics Unit, Bergonié Cancer Institute, Bordeaux, France
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: ML RI NS. Performed the experiments: AR GB. Analyzed the data: GM RI AR EL AdR NE. Contributed reagents/materials/analysis tools: EBS ML LV IC. Wrote the paper: RI ML AR. Performed mutation screening: NJ FB NS.